The Egypt Neurology Clinical Trials market is projected to grow from $14.6 Mn in 2022 to $25.2 Mn by 2030, registering a CAGR of 7% during the forecast period of 2022 - 2030. The market will be driven by the increasing involvement from both global and local companies, a supportive regulatory environment and a growing pool of qualified professionals. The market is segmented by phase, by study design & by indication. Some of the major players include Pfizer, Novartis, Minapharm Pharmaceuticals & EIPICO.
The Egypt Neurology Clinical Trials market is projected to grow from $14.6 Mn in 2022 to $25.2 Mn by 2030, registering a CAGR of 7% during the forecast period of 2022 - 2030. Egypt has a robust manufacturing sector and is the MENA region's top manufacturer of pharmaceuticals. According to Pharmaconex, about 9 out of 10 pharmaceuticals taken in the nation are manufactured domestically. Epilepsy is one of the most prevalent neurological illnesses, with a global frequency ranging from 5 to 10 per 1000 people, with significant variations depending on location. In Egypt, the frequency was 6.98 per 1000 people. According to the latest WHO statistics released in 2020, Alzheimer's & Dementia Deaths in Egypt totalled 6,975 or 1.30% of total fatalities.
Egypt has been more involved in neurology clinical trials in recent years. Due to various considerations, including the country's enormous population, the availability of skilled clinical research personnel, and a supportive regulatory framework, there is a rising interest among both global and local pharmaceutical firms in conducting clinical trials in Egypt.
In Egypt, neurology clinical trials are being conducted for a variety of illnesses and ailments, including Alzheimer's disease, multiple sclerosis, Parkinson's disease, and stroke. Alzheimer's disease has received special attention in recent years, with multiple clinical studies ongoing to investigate potential therapies for this devastating disorder.
The Egyptian government has also made measures to encourage the expansion of clinical trials in the nation. The Egyptian Ministry of Health has developed clinical trial standards and a simplified clearance procedure for new studies. In addition, the government has formed the Clinical Trials Ethics Commission, which is in charge of ensuring that clinical trials in the country are done ethically and in accordance with international norms.
In addition to multinational pharmaceutical businesses, some Egyptian companies are involved in neurology clinical trials. These firms are working to provide novel medicines for a variety of neurological illnesses, including epilepsy and Parkinson's disease.
Market Growth Drivers
Since Egypt has a huge population, there is a vast pool of possible patients for clinical studies. Egypt has an advanced healthcare system and a rising number of skilled healthcare workers, including doctors and clinical research specialists. This facilitates pharmaceutical firms conducting clinical trials in the nation. The Egyptian government has developed clinical trial standards and a simplified approval procedure for new studies. In addition, the government has formed the Clinical Trials Ethics Commission, which is in charge of ensuring that clinical trials in the country are done ethically and in accordance with international norms. Clinical trials provide Egyptian patients access to novel therapies that are not yet accessible in the nation. This is especially significant for people suffering from neurological illnesses, for whom therapeutic choices are often restricted.
Egypt has seen political unrest in recent years, which may generate uncertainty for pharmaceutical firms interested in conducting clinical trials there. Funding for clinical trials in Egypt may be restricted, which may make it difficult for certain pharmaceutical firms to perform studies in the nation. While Egypt has a well-developed healthcare system, there could be insufficient infrastructure in certain locations, making clinical trials in specific areas challenging. Moreover, cultural variations between Egypt and other nations may impact the conduct of clinical studies. To meet these variances, pharmaceutical firms might have to adapt their trial techniques.
April 2022, Hikma Pharmaceuticals PLC, a worldwide pharmaceutical firm, announced the completion of its purchase of Custopharm Inc. ('Custopharm') from Water Street Healthcare Partners ('Water Street'), subject to US Federal Trade Commission clearance.
1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Clinical Trials Regulation in Country
1.6 Recent Developments in the Country
2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)
3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints
4. Competitive Landscape
4.1 Major Market Share
4.2 Key Company Profile (Check all Companies in the Summary Section)
126.96.36.199 Product Applications and Services
188.8.131.52 Recent Developments
184.108.40.206 Partnerships Ecosystem
220.127.116.11 Financials (Based on Availability)
5. Reimbursement Scenario
5.1 Reimbursement Regulation
6. Methodology and Scope
By Phase (Revenue, USD Billion):
By Study Design Outlook (Revenue, USD Billion):
By Indication Outlook (Revenue, USD Billion):
Insights10 will provide you with the reports within 10 key parameters which are:
Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.
Stage I: Market Data Collection
Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.
Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.
Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:
Stage II: Market Data Analysis and Statistical Model
Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.
Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.
The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.
The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.
Data Triangulation & Validation:
Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.
We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.
Stage III: Interpretation and Presentation
Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)
Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to oﬀer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.
Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.
We value your inquiry and offer free customization with every report to fulfil your exact research needs.
This report addresses